Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Five Year Clinical Survival Rate of Metal-Ceramic Single Crowns is Similar to All-Ceramic Single Crowns (UT CAT #2983).

Kaddour-Djebba A, Jones JD, Connor J.

Tex Dent J. 2016 Apr;133(4):250. No abstract available.

PMID:
27266010
2.

Use of ChemoFx® for Identification of Effective Treatments in Epithelial Ovarian Cancer.

Richard S, Wells A, Connor J, Price F.

PLoS Curr. 2015 Jul 13;7. pii: ecurrents.eogt.8b0b6fffc7b999b34bc4c8152edbf237. doi: 10.1371/currents.eogt.8b0b6fffc7b999b34bc4c8152edbf237.

3.

Intensive postoperative glucose control reduces the surgical site infection rates in gynecologic oncology patients.

Al-Niaimi AN, Ahmed M, Burish N, Chackmakchy SA, Seo S, Rose S, Hartenbach E, Kushner DM, Safdar N, Rice L, Connor J.

Gynecol Oncol. 2015 Jan;136(1):71-6. doi: 10.1016/j.ygyno.2014.09.013.

4.

Role of transportation in spread of porcine epidemic diarrhea virus infection, United States.

Lowe J, Gauger P, Harmon K, Zhang J, Connor J, Yeske P, Loula T, Levis I, Dufresne L, Main R.

Emerg Infect Dis. 2014 May;20(5):872-4. doi: 10.3201/eid2005.131628.

5.

Angiosarcoma originating from an ovarian mature teratoma, a rare disease with complex treatment modalities.

Albertin C, Johnson KA, Connor JP, Al-Niaimi AN.

Gynecol Oncol Case Rep. 2013 Feb 11;5:31-3. doi: 10.1016/j.gynor.2013.02.001.

6.
7.

A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors.

Connor JP, Cristea MC, Lewis NL, Lewis LD, Komarnitsky PB, Mattiacci MR, Felder M, Stewart S, Harter J, Henslee-Downey J, Kramer D, Neugebauer R, Stupp R.

BMC Cancer. 2013 Jan 15;13:20. doi: 10.1186/1471-2407-13-20.

8.

Calorimetric determination of rate constants and enthalpy changes for zero-order reactions.

Almeida e Sousa L, Beezer AE, Hansen LD, Clapham D, Connor JA, Gaisford S.

J Phys Chem B. 2012 Jun 7;116(22):6356-60. doi: 10.1021/jp302933f.

PMID:
22607190
9.
10.

Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: long-term follow-up of a prospective trial.

Engle DB, Connor JP, Morris PC, Bender DP, De Geest K, Ahmed A, Goodheart MJ.

Arch Gynecol Obstet. 2012 Sep;286(3):717-21. doi: 10.1007/s00404-012-2351-1.

PMID:
22569711
11.

Uterine leiomyosarcoma diffusely express disialoganglioside GD2 and bind the therapeutic immunocytokine 14.18-IL2: implications for immunotherapy.

Ziebarth AJ, Felder MA, Harter J, Connor JP.

Cancer Immunol Immunother. 2012 Jul;61(7):1149-53. doi: 10.1007/s00262-012-1267-8.

PMID:
22562378
12.

The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia.

Tyler C, Kapur A, Felder M, Belisle JA, Trautman C, Gubbels JA, Connor JP, Patankar MS.

Am J Reprod Immunol. 2012 Jul;68(1):28-37. doi: 10.1111/j.1600-0897.2012.01113.x.

13.

The immunomodulating roles of glycoproteins in epithelial ovarian cancer.

Patankar MS, Gubbels JA, Felder M, Connor JP.

Front Biosci (Elite Ed). 2012 Jan 1;4:631-50. Review.

14.

Quality of life in cervical cancer survivors: patient and provider perspectives on common complications of cervical cancer and treatment.

Einstein MH, Rash JK, Chappell RJ, Swietlik JM, Hollenberg JP, Connor JP.

Gynecol Oncol. 2012 Apr;125(1):163-7. doi: 10.1016/j.ygyno.2011.10.033.

PMID:
22063460
15.

Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.

Gubbels JA, Gadbaw B, Buhtoiarov IN, Horibata S, Kapur AK, Patel D, Hank JA, Gillies SD, Sondel PM, Patankar MS, Connor J.

Cancer Immunol Immunother. 2011 Dec;60(12):1789-800. doi: 10.1007/s00262-011-1072-9.

16.

HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy.

Xiang X, Feng M, Felder M, Connor JP, Man YG, Patankar MS, Ho M.

J Cancer. 2011;2:280-91.

17.
18.

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.

Belisle JA, Horibata S, Jennifer GA, Petrie S, Kapur A, André S, Gabius HJ, Rancourt C, Connor J, Paulson JC, Patankar MS.

Mol Cancer. 2010 May 24;9:118. doi: 10.1186/1476-4598-9-118.

19.

The detection, treatment, and biology of epithelial ovarian cancer.

Gubbels JA, Claussen N, Kapur AK, Connor JP, Patankar MS.

J Ovarian Res. 2010 Mar 29;3:8. doi: 10.1186/1757-2215-3-8.

20.

MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells.

Gubbels JA, Felder M, Horibata S, Belisle JA, Kapur A, Holden H, Petrie S, Migneault M, Rancourt C, Connor JP, Patankar MS.

Mol Cancer. 2010 Jan 20;9:11. doi: 10.1186/1476-4598-9-11.

Items per page

Supplemental Content

Loading ...
Support Center